Open9.120 | Close8.990 |
Vol / Avg.534.197K / 675.375K | Mkt Cap315.709M |
Day Range8.970 - 9.480 | 52 Wk Range7.600 - 28.250 |
Harrow Stock (NASDAQ: HROW) stock price, news, charts, stock research, profile.
Open9.120 | Close8.990 |
Vol / Avg.534.197K / 675.375K | Mkt Cap315.709M |
Day Range8.970 - 9.480 | 52 Wk Range7.600 - 28.250 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.040 | -0.090 | -0.1300 | ||||
REV | 37.580M | 34.265M | -3.315M |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.040 | -0.020 | 0.0200 | ||||
REV | 31.040M | 33.470M | 2.430M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-07-20 | B. Riley Securities | Sahil Kazmi | Maintains | BuyBuy | Raises | 42.00 | 45.00 |
2023-04-17 | Lake Street | Brooks O'Neil | Maintains | Buy | Raises | 24.00 | 37.00 |
2022-09-08 | B. Riley Securities | Sahil Kazmi | Reinstates | Buy | Announces | - | 17.00 |
2022-05-20 | B. Riley Securities | Justin Walsh | Maintains | Buy | Raises | 17.00 | 20.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
HROW | Harrow | -0.11% | 315.7M |
AVIR | Atea Pharmaceuticals | 4.14% | 252M |
THRD | Third Harmonic Bio | 4.9% | 328.1M |
ZVRA | Zevra Therapeutics | 2.1% | 190.8M |
GHRS | GH Research | -5.78% | 322M |
You can purchase shares of Harrow (NASDAQ: HROW) through any online brokerage.
Other companies in Harrow’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA), GH Research (NASDAQ:GHRS) and SNDL (NASDAQ:SNDL).
The latest price target for Harrow (NASDAQ: HROW) was reported by B. Riley Securities on Thursday, July 20, 2023. The analyst firm set a price target for 45.00 expecting HROW to rise to within 12 months (a possible 400.56% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Harrow (NASDAQ: HROW) is $8.99 last updated Today at November 29, 2023 at 9:20 PM UTC.
There is no dividend information for Harrow.
Harrow’s Q3 earnings are confirmed for Monday, November 13, 2023.
There is no upcoming split for Harrow.
Harrow is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.